Alimera Sciences Investor Relations Material

Latest events

Q1 2024

Alimera Sciences

Q2 2024

6 Aug, 2024

Q1 2024

14 May, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Alimera Sciences Inc

Access all reports
Alimera Sciences Inc. is a pharmaceutical company focused on the development and commercialization of prescription ophthalmic treatments. The company specializes in therapies for retinal diseases, aiming to improve vision and quality of life for patients. The company is headquartered in Alpharetta, Georgia, and its shares are listed on the NASDAQ.